2020
DOI: 10.1016/j.hjc.2020.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Expert consensus statement for the management of patients with embolic stroke of undetermined source and patent foramen ovale: A clinical guide by the working group for stroke of the Hellenic Society of Cardiology and the Hellenic Stroke Organization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…This finding should be attributed to the pragmatic nature and, in particular, to the fact that the detection of PFO in patients older than 60 years is of little importance in the management of most patients according to current knowledge. 8,9 Atrial cardiopathy was defined based on clinically relevant electro-and echocardiography markers of left atrial enlargement and dysfunction, while several conditions or serum biomarkers possibly related to atrial cardiopathy were not included in the analysis. The strengths of the analysis include the large number of consecutive ESUS patients, its multicenter design, the definition of ESUS according to widely accepted criteria, 1 and the definition of atrial cardiopathy by multiple recommended criteria.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This finding should be attributed to the pragmatic nature and, in particular, to the fact that the detection of PFO in patients older than 60 years is of little importance in the management of most patients according to current knowledge. 8,9 Atrial cardiopathy was defined based on clinically relevant electro-and echocardiography markers of left atrial enlargement and dysfunction, while several conditions or serum biomarkers possibly related to atrial cardiopathy were not included in the analysis. The strengths of the analysis include the large number of consecutive ESUS patients, its multicenter design, the definition of ESUS according to widely accepted criteria, 1 and the definition of atrial cardiopathy by multiple recommended criteria.…”
Section: Discussionmentioning
confidence: 99%
“…[23][24][25][26] With regard to PFO, although it is now clear that percutaneous closure of PFO reduces the risk of stroke recurrence in patients younger than 60 years of age, there are many other questions still open, like whether percutaneous PFO closure is beneficial in older patients, and whether the echocardiographic characteristics of the PFO (e.g., the size of the shunt and the presence of atrial septal aneurysm) and the clinical characteristics of the patient (e.g., the RoPE score) could identify a subpopulation which may benefit by percutaneous PFO closure beyond current recommendations. 8,9,[27][28][29] Ongoing and future research will hopefully address many of these open questions and facilitate the improvement of outcomes in this population.…”
Section: Thrombosis and Haemostasismentioning
confidence: 99%
See 1 more Smart Citation
“…Fourth, this TCD bubble test for RLS should be interpreted only as a second line to a classical workup flowchart for syncope at present. The prevalence of RLS (15-25%) is also high in the asymptomatic population (19). Therefore, our findings should not prevent diagnosis of other severe causes that need to be promptly addressed.…”
Section: Discussionmentioning
confidence: 67%
“…It is estimated that RLS can be found in 15-25% of the general population (19); however, the prevalence of RLS in patients with unexplained syncope is still unclear. The clinical relevance of RLS mainly involves migraine and cryptogenic stroke (ischemic stroke with unknown causes) (7,8,20).…”
Section: Sample Size Calculationmentioning
confidence: 99%